FDAClass IIIDecember 24, 2025

HemosIL SynthAFax recall

HemosIL SynthAFax. Partial Thromboplastin Time Tests.

Why was HemosIL SynthAFax recalled?

Recalled lots were manufactured with double the amount of preservative concentration.

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Part No. 0020007400; UDI: 08426950087649; Lot No. (Exp. Date) N0542231(2026-06-30), N0250088(2027-04-30, N0452249 (2027-06-30).

Product
HemosIL SynthAFax. Partial Thromboplastin Time Tests.
Recalling firm
Instrumentation Laboratory
Quantity
4,506 units
Distribution
Domestic: CA, CO, FL, NY; Foreign: AR, AT, CA, CZ, DE, DK, ES, FR, GB, IE, IL, IN, IT, JP, LK, NL, PL, PT, RO, RS, TH, VN.
Recall date
December 24, 2025
Classification
Class III
Status
Ongoing
Agency
FDA (device)
Open FDA enforcement record Latest recalls